| Gene symbol | GUCY2C | Synonyms | DIAR6, GC-C, GCC, GUC2C, HSER, MECIL, MUCIL, STAR | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p12.3 | dbXrefs | |
| Description | guanylate cyclase 2C | ||||
| GTO ID | GTC0957 |
| Trial ID | ChiCTR2100053828 |
| Disease | Colorectal Cancer | Gastric Cancer | Liver Cancer | Pancreatic Cancer | Esophageal Adenocarcinoma | Esophagogastric Junction Cancer |
| Altered gene | GUCY2C |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GUCY2C CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical study on the safety and effectiveness of CAR-T cells in the treatment of advanced GUCY2C-positive digestive system tumors |
| Year | 2021 |
| Country | China |
| Company sponsor | The First Bethune Hospital of Jilin University |
| Cohort 1 | |||||||
|
|||||||